Try our Advanced Search for more refined results

Expert Analysis

Is Mayo V. Prometheus Really A Game Changer?

Law360, New York (April 11, 2012, 12:31 PM EDT) -- On March 21, 2012, the U.S. Supreme Court invalidated patent claims directed to "optimizing the therapeutic efficacy" of a drug by administering the drug to a patient and determining the level of the drug's metabolic byproducts in the patient's blood. In Mayo Collaborative Services v. Prometheus Laboratories Inc., the Supreme Court unanimously held that such claims were directed to unpatentable "laws of nature" rather than patentable applications of such laws....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!